Fresenius Medical Care’s Q3 sales surpass $3 billion
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) posted net income of $270.0 million, or 82 cents per diluted share, on sales of $3.06 billion during the three months ended Sept. 30 That compares with net income of approximately $244.5 million, or 76 cents per diluted share, on sales of $2.89 billion during the same period last year.
Read more
Exactech profits narrow on lower sales
Exactech Inc. (NSDQ:EXAC) reported profits of $1.5 million, or 11 cents per diluted share, on revenue of $42.0 million during the three months ended Sept. 30. That compares with profits of $2.7 million, or 21 cents per diluted share, on revenue of $42.4 million during the same period last year.
Read more
STAAR Surgical remains in the red, but its sales get a small bump
STAAR Surgical Co. (NSDQ:STAA) reported a loss of $1.2 million, or 3 cents per diluted share, on revenue of $13.2 million during the three months ended Oct. 1. That compares with a loss of $2.0 million, or 5 cents per diluted share, on revenue of $12.5 million during the same period last year.
Read more
Solta Medical sees 40 percent revenue increase, losses narrow
Solta Medical Inc. (NSDQ:SLTM) posted a loss of $1.4 million, or 2 cents per diluted share, on sales of $24.9 million during the three months ended Sept. 30. That compares with a net loss of $6.2 million, or 13 cents per diluted share, on sales of $17.8 million during the same period last year.
Read more
Masimo net income rises on 15 percent sales increase
Masimo Corp. (NSDQ:MASI) reported profits of $16.4 million, or 27 cents per diluted share, on sales of $101.0 million during the three months ended Oct. 2. That compares with profits of $13.1 million, or 22 cents per diluted share, on sales of $87.4 million during the same period last year.
Read more
Orthovita shrinks losses on revenue increase
Orthovita Inc. (NSDQ:VITA) recorded a loss of approximately $283,000, equall to about 0 cents per diluted share, on sales of $23.3 million during the three months ended Sept. 30. That compares with a loss of $1.7 million, or 2 cents per diluted share, on sales of $22.3 million during the same period last year.
Read more
CareFusion’s profits shrink 53 percent
CareFusion Corp. (NYSE:CFN) posted a profit of $38 million, or 17 cents per diluted share, on revenue of $908 million during the three months ended Sept. 30. That compares with profits of $81 million, or 37 cents per diluted share, on revenue of $923 million during the same period last year.
Read more
